DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+4.33%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$1.96B
AUM Growth
–
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
74.95%
Top 10 Holdings %
Top 10 Hldgs %
30.18%
Holding
110
New
89
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$80.7M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$55.8M |
| 3 |
Pfizer
PFE
|
$52M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$49.4M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$48.7M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 54.94% |
| 2 | Technology | 1.71% |
| 3 | Financials | 1.14% |
| 4 | Energy | 0.02% |
| 5 | Consumer Discretionary | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUXL
1
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $80.7M | 3.8% | +4,850,644 | New | +$80.7M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $55.8M | 2.63% | +3,909,914 | New | +$55.8M |
|
|
3
Pfizer
PFE
$141B
| $52M | 2.45% | +1,855,000 | New | +$52M |
|
|
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
| $49.4M | 2.33% | +10,885,406 | New | +$49.4M |
|
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $48.7M | 2.3% | +1,242,759 | New | +$48.7M |
|
6
AstraZeneca
AZN
$248B
| $43.9M | 2.07% | +928,000 | New | +$43.9M |
|
|
KERX
7
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $43.8M | 2.06% | +5,864,612 | New | +$43.8M |
|
|
OPTR
8
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $43.8M | 2.06% | +3,025,829 | New | +$43.8M |
|
|
SGNT
9
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $43.7M | 2.06% | +2,082,167 | New | +$43.7M |
|
|
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
| $39.1M | 1.84% | +9,400,000 | New | +$39.1M |
|
|
FRX
11
DELISTED
FOREST LABORATORIES INC
FRX
| $38.7M | 1.83% | +945,000 | New | +$38.7M |
|
|
INFI
12
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $38.1M | 1.8% | +2,354,963 | New | +$38.1M |
|
13
Nektar Therapeutics
NKTR
$568M
| $34M | 1.6% | +2,939,741 | New | +$34M |
|
|
CBST
14
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $33.6M | 1.58% | +695,000 | New | +$33.6M |
|
15
Cardinal Health
CAH
$35.5B
| $33M | 1.56% | +700,000 | New | +$33M |
|
|
AGN
16
DELISTED
ALLERGAN INC
AGN
| $31.6M | 1.49% | +375,300 | New | +$31.6M |
|
17
AngioDynamics
ANGO
$417M
| $29.9M | 1.41% | +2,651,466 | New | +$29.9M |
|
18
Community Health Systems
CYH
$387M
| $29.8M | 1.41% | +636,124 | New | +$29.8M |
|
|
AIRM
19
DELISTED
Air Methods Corp
AIRM
| $29.4M | 1.39% | +869,025 | New | +$29.4M |
|
|
TRNX
20
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $28.8M | 1.36% | +1,646,318 | New | +$28.8M |
|
|
UAM
21
DELISTED
Universal American Corp
UAM
| $27.2M | 1.28% | +3,065,003 | New | +$27.2M |
|
22
Merck
MRK
$210B
| $26.7M | 1.26% | +575,000 | New | +$26.7M |
|
|
AVDL
23
Avadel Pharmaceuticals
AVDL
$1.43B
| $26.6M | 1.25% | +4,333,475 | New | +$26.6M |
|
24
AbbVie
ABBV
$372B
| $25.5M | 1.2% | +617,000 | New | +$25.5M |
|
|
STJ
25
DELISTED
St Jude Medical
STJ
| $24M | 1.13% | +525,000 | New | +$24M |
|